We evaluated whether the lack of TNF-α signaling increases mucosal levels of annexin A1 (AnxA1); the hypothesis stems from previous findings showing that TNF-α neutralization in Crohn´s disease patients up-regulates systemic AnxA1 expression. Biopsies from healthy volunteers and patients under anti-TNF-α therapy with remittent ulcerative colitis (UC) showed higher AnxA1 expression than those with active disease. We also evaluated dextran sulfate sodium (DSS)-acute colitis in TNF-α receptor 1 KO (TNFR1-/-) strain with impaired TNF-α signaling and C57BL/6 (WT) mice. Although both strains developed colitis, TNFR1-/- mice showed early clinical recovery, lower myeloperoxidase (MPO) activity and milder histopathological alterations. Colonic epith...
Background & aimsInflammatory bowel diseases (IBDs) are multifactorial diseases commonly treated...
Annexin A1 (ANXA1) inhibits NF-kB, a key regulator of inflammation, the common pathophysiological me...
Tumor necrosis factor-a (TNF-a) is a key factor for the pathogenesis of inflammatory bowel diseases ...
TNF-α is involved in the mechanisms that initiate inflammatory bowel diseases (IBDs). Anti-TNF-α dru...
Development of inflammatory bowel disease (IBD) involves the interplay of environmental and genetic ...
Development of inflammatory bowel disease (IBD) involves the interplay of environmental and genetic ...
Background: Development of inflammatory bowel disease (IBD) involves the interplay of environmental ...
BackgroundDevelopment of inflammatory bowel disease (IBD) involves the interplay of environmental an...
BackgroundDevelopment of inflammatory bowel disease (IBD) involves the interplay of environmental an...
Background: Development of inflammatory bowel disease (IBD) involves the interplay of environmental ...
PubMed ID: 22723974This is an open-access article distributed under the terms of the Creative Common...
Objectives: Targeting tumor necrosis factor (TNF) with biologic agents, such as infliximab and adali...
<div><p>Annexin A1 (ANXA1) inhibits NF-κB, a key regulator of inflammation, the common pathophysiolo...
AbstractBackground/aims: High levels of pro-inflammatory cytokines are linked to inflammatory bowel ...
Background & aimsInflammatory bowel diseases (IBDs) are multifactorial diseases commonly treated...
Background & aimsInflammatory bowel diseases (IBDs) are multifactorial diseases commonly treated...
Annexin A1 (ANXA1) inhibits NF-kB, a key regulator of inflammation, the common pathophysiological me...
Tumor necrosis factor-a (TNF-a) is a key factor for the pathogenesis of inflammatory bowel diseases ...
TNF-α is involved in the mechanisms that initiate inflammatory bowel diseases (IBDs). Anti-TNF-α dru...
Development of inflammatory bowel disease (IBD) involves the interplay of environmental and genetic ...
Development of inflammatory bowel disease (IBD) involves the interplay of environmental and genetic ...
Background: Development of inflammatory bowel disease (IBD) involves the interplay of environmental ...
BackgroundDevelopment of inflammatory bowel disease (IBD) involves the interplay of environmental an...
BackgroundDevelopment of inflammatory bowel disease (IBD) involves the interplay of environmental an...
Background: Development of inflammatory bowel disease (IBD) involves the interplay of environmental ...
PubMed ID: 22723974This is an open-access article distributed under the terms of the Creative Common...
Objectives: Targeting tumor necrosis factor (TNF) with biologic agents, such as infliximab and adali...
<div><p>Annexin A1 (ANXA1) inhibits NF-κB, a key regulator of inflammation, the common pathophysiolo...
AbstractBackground/aims: High levels of pro-inflammatory cytokines are linked to inflammatory bowel ...
Background & aimsInflammatory bowel diseases (IBDs) are multifactorial diseases commonly treated...
Background & aimsInflammatory bowel diseases (IBDs) are multifactorial diseases commonly treated...
Annexin A1 (ANXA1) inhibits NF-kB, a key regulator of inflammation, the common pathophysiological me...
Tumor necrosis factor-a (TNF-a) is a key factor for the pathogenesis of inflammatory bowel diseases ...